Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.51 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.51 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.51 |
| ▸ | PGR | P06401 | 1/20 | 0.51 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | MGLL | Q99685 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 4/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | CNR1 | P21554 | 1/20 | 0.45 |
| ▸ | DGKA | P23743 | 2/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.42 |
| ▸ | PPARG | P37231 | 3/20 | 0.42 |
| ▸ | OXER1 | Q8TDS5 | 3/20 | 0.42 |
| ▸ | RXRA | P19793 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3944018 | 1.00 | ADORA3 (0.51) | ADORA3NR1I2PTGS2PGRPDE4D | |
| SCHEMBL309027 | 1.00 | ADORA3 (0.51) | ADORA3NR1I2PTGS2PGRPDE4D | |
| Acetic Acid SCHEMBL31534018 | 0.94 | ADORA3 (0.47) | ADORA3NR1I2PTGS2PGRPDE4D | |
| SCHEMBL29255856 | 0.94 | ADORA3 (0.60) | ADORA3NR1I2PTGS2PGRPDE4D | |
| Butyric Acid SCHEMBL1866744 | 0.93 | ALDH1A1 (0.50) | ADORA3NR1I2PTGS2PGRPDE4D | |
| Butyric Acid SCHEMBL1866742 | 0.93 | ALDH1A1 (0.50) | ADORA3NR1I2PTGS2PGRPDE4D | |
| SCHEMBL16568217 | 0.92 | ADORA3 (0.55) | ADORA3NR1I2PTGS2PGRPDE4D | |
| SCHEMBL22832722 | 0.92 | ADORA3 (0.55) | ADORA3NR1I2PTGS2PGRPDE4D | |
| SCHEMBL22832723 | 0.92 | ADORA3 (0.55) | ADORA3NR1I2PTGS2PGRPDE4D | |
| SCHEMBL28859892 | 0.90 | MGLL (0.47) | ADORA3NR1I2PTGS2PGRPDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 898 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12589377-B2 | Encapsulated composition comprising core-shell microcapsules and process for its preparation | GIVAUDAN SA (CH) | 2026-03-31 | — | — | US | claimed |
| EP-4695016-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2026-02-18 | — | — | EP | claimed |
| EP-4655373-A1 | BIODEGRADABLE PERFUME COMPOSITION | Givaudan SA (CH) | 2025-12-03 | — | — | EP | claimed |
| US-20250295826-A1 | FRAGRANCES AS UREASE INHIBITORS | SYMRISE AG (DE) | 2025-09-25 | — | — | US | claimed |
| US-12398341-B2 | Apparatus and compositions for improving scent delivery | THE PROCTER & GAMBLE COMPANY (US) | 2025-08-26 | — | — | US | claimed |
| US-20250129312-A1 | CONSUMER PRODUCT COMPOSITIONS WITH PERFUME ENCAPSULATES | PROCTER & GAMBLE (US) | 2025-04-24 | — | — | US | claimed |
| EP-4527191-A1 | UREASE INHIBITORS | Symrise AG (DE) | 2025-03-26 | — | — | EP | claimed |
| US-12247180-B2 | Apparatus and compositions for improving scent delivery | THE PROCTER & GAMBLE COMPANY (US) | 2025-03-11 | — | — | US | claimed |
| EP-4496468-A1 | FRAGRANCES AS UREASE INHIBITORS | Symrise AG (DE) | 2025-01-29 | — | — | EP | claimed |
| EP-4096618-B1 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | SYMRISE AG (DE) | 2025-01-29 | — | — | EP | claimed |
| WO-2016049396-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2016049455-A1 | PERSONAL CARE COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| US-20160089317-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| WO-2016049407-A1 | ABSORBENT ARTICLE COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| US-20160090556-A1 | PRODUCTS COMPRISING MALODOR REDUCTION MATERIALS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| WO-2016049398-A1 | FRESHENING COMPOSITIONS AND DEVICES COMPRISING SAME | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2016049395-A1 | PRODUCTS COMPRISING MALODOR REDUCTION MATERIALS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| CN-104351177-A | Lygus pratensis linnaeus attractant and application thereof | INST PLANT PROTECTION IPP CAAS | 2015-02-18 | — | — | CN | claimed |
| EP-1545220-A1 | ATTRACTANT FOR APPLE FRUIT MOTH AND OTHER INSECT PESTS OF APPLE | Forskarpatent i Syd AB (SE) | 2005-06-29 | — | — | EP | claimed |
| WO-2004028256-A1 | ATTRACTANT FOR APPLE FRUIT MOTH AND OTHER INSECT PESTS OF APPLE | FORSKARPATENT I SYD AB (SE) | 2004-04-08 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12589377-B2 | Encapsulated composition comprising core-shell microcapsules and process for its preparation | CUTA, EXOC1, EXOSC10 | ADORA3 4838/4885NR1I2 4294/4885PTGS2 3147/4885 |
| US-20160089317-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | LPO, QDPR, TYR | ADORA3 2556/4885NR1I2 1139/4885PTGS2 2166/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.